Behavioral effects of γ-hydroxybutyrate, its precursor γ-butyrolactone, and GABAB receptor agonists: Time course and differential antagonism by the GABAB receptor antagonist 3-aminopropyl(diethoxymethyl)phosphinic acid (CGP35348)

Journal of Pharmacology and Experimental Therapeutics

Volumn 330, Issue 3, 2009, Pages 876-883

  Koek, Wouter ^a,d   Mercer, Susan L ^b   Coop, Andrew ^c   France, Charles P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b LIPSCOMB UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 3 AMINOPROPYL(METHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 4 HYDROXYBUTYRIC ACID; BACLOFEN; GAMMA BUTYROLACTONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG POTENCY; DRUG RECEPTOR BINDING; INSTRUMENTAL CONDITIONING; NONHUMAN; PIGEON; PRIORITY JOURNAL; REINFORCEMENT;

4-BUTYROLACTONE; ANESTHETICS, INTRAVENOUS; ANIMALS; BACLOFEN; COLUMBIDAE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA AGONISTS; GABA ANTAGONISTS; INJECTIONS, INTRAMUSCULAR; KINETICS; ORGANOPHOSPHORUS COMPOUNDS; RECEPTORS, GABA-B; SODIUM OXYBATE;

EID: 70349091922     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.151845     Document Type: Article

References (41)

1. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14:48-58.
2. Benavides J, Rumigny JF, Bourguignon JJ, Cash C, Wermuth CG, Mandel P, Vincendon G, and Maitre M (1982) High affinity binding sites for gammahydroxybutyric acid in rat brain. Life Sci 30:953-961.
3. B receptor subtypes in the rat cerebral cortex. J Pharmacol Exp Ther 262: 114-118.
4. Carai MA, Colombo G, Brunetti G, Melis S, Serra S, Vacca G, Mastinu S, Pistuddi AM, Solinas C, Cignarella G, et al. (2001) Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. Eur J Pharmacol 428: 315-321. (Pubitemid 33016647)
5. Carter LP, Chen W, Coop A, Koek W, and France CP (2006) Discriminative stimulus effects of GHB and GABA(B) agonists are differentially attenuated by CGP35348. Eur J Pharmacol 538:85-93.
6. Carter LP, Flores LR, Wu H, Chen W, Unzeitig AW, Coop A, and France CP (2003) The role of GABAB receptors in the discriminative stimulus effects of γ-hydroxybutyrate in rats: time course and antagonism studies. J Pharmacol Exp Ther 305:668-674. (Pubitemid 36459185)
7. Carter LP, Koek W, and France CP (2009) Behavioral analyses of GHB: receptor mechanisms. Pharmacol Ther 121:100-114.
8. Carter LP, Wu H, Chen W, Cruz CM, Lamb RJ, Koek W, Coop A, and France CP (2004) Effects of gamma-hydroxybutyrate (GHB) on schedule-controlled responding in rats: Role of GHB and GABAB receptors. J Pharmacol Exp Ther 308:182-188. (Pubitemid 38090716)
9. Carter LP, Wu H, Chen W, Matthews MM, Mehta AK, Hernandez RJ, Thomson JA, Ticku MK, Coop A, Koek W, et al. (2005) Novel gamma-hydroxybutyric acid (GHB) analogs share some, but not all, of the behavioral effects of GHB and GABAB receptor agonists. J Pharmacol Exp Ther 313:1314-1323. (Pubitemid 40727037)
10. Colombo G, Agabio R, Lobina C, Reali R, and Gessa GL (1998) Involvement of GABA(A) and GABA(B) receptors in the mediation of discriminative stimulus effects of gamma-hydroxybutyric acid. Physiol Behav 64:293-302. (Pubitemid 28458951)
11. Cruz HG, Ivanova T, Lunn ML, Stoffel M, Slesinger PA, and Lüscher C (2004) Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system. Nat Neurosci 7:153-159. (Pubitemid 38129791)
12. Draper N and Smith H (1998) Checking the straight line fit, in Applied Regression Analysis, 3rd ed, pp 47-56, Wiley Interscience, Malden, MA.
13. Fassio A, Bonanno G, Cavazzani P, and Raiteri M (1994) Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABAB receptor. Eur J Pharmacol 263:311-314. (Pubitemid 24301310)
14. Fuller DE and Hornfeldt CS (2003) From club drug to orphan drug: sodium oxybate (xyrem) for the treatment of cataplexy. Pharmacotherapy 23:1205-1209.
15. Gerak LR and France CP (2007) Time-dependent decreases in apparent pA2 values for naltrexone studied in combination with morphine in rhesus monkeys. Psychopharmacology (Berl) 193:315-321.
16. Gonzalez A and Nutt DJ (2005) Gamma hydroxy butyrate abuse and dependency. J Psychopharmacol 19:195-204. (Pubitemid 40577225)
17. Goodwin AK, Froestl W, and Weerts EM (2005) Involvement of gammahydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons. Psychopharmacology (Berl) 180:342-351. (Pubitemid 40909680)
18. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
19. Kaupmann K, Cryan JF, Wellendorph P, Mombereau C, Sansig G, Klebs K, Schmutz M, Froestl W, van der Putten H, Mosbacher J, et al. (2003) Specific gamma-hydroxybutyrate- binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci 18:2722-2730. (Pubitemid 37542125)
20. Kenakin T (1997) Competitive antagonism, in Pharmacologic Analysis of Drug- Receptor Interaction, 3rd ed, pp 331-373, Lippincott-Raven, Philadelphia, PA.
21. Kerr DI, Ong J, Doolette DJ, Abbenante J, and Prager RH (1993) 3-Amino-2-(4- chlorophenyl)-nitropropane is a new GABAB receptor agonist, more active peripherally. Eur J Pharmacol 236:239-245. (Pubitemid 23158302)
22. Koek W, Chen W, Mercer SL, Coop A, and France CP (2006) Discriminative stimulus effects of γ-hydroxybutyrate: role of training dose. J Pharmacol Exp Ther 317: 409-417.
23. B receptors. J Pharmacol Exp Ther 308:904-911.
24. Koek W and France CP (2008) Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: Mediation by GABA(B) receptors, but differential enhancement by N-methyl-D-aspartate (NMDA) receptor antagonists. Psychopharmacology (Berl) 199:191-198.
25. Koek W, Khanal M, and France CP (2007a) Synergistic interactions between 'club drugs': gamma-hydroxybutyrate and phencyclidine enhance each other's discriminative stimulus effects. Behav Pharmacol 18:807-810.
26. B receptor antagonist CGP35348. Psychopharmacology (Berl) 192:407-414.
27. Lanza M, Fassio A, Gemignani A, Bonanno G, and Raiteri M (1993) CGP 52432: A novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex. Eur J Pharmacol 237:191-195. (Pubitemid 23201826)
28. Li Q, Kuhn CM, Wilson WA, and Lewis DV (2007) Effects of gamma hydroxybutyric acid on inhibition and excitation in rat neocortex. Neuroscience 150:82-92. (Pubitemid 350198689)
29. Maitre M (1997) The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 51:337-361.
30. B receptor agonist. Eur J Pharmacol 321:67-75.
31. Olianas MC and Onali P (1999) GABA(B) receptor-mediated stimulation of adenylyl cyclase activity in membranes of rat olfactory bulb. Br J Pharmacol 126:657-664. (Pubitemid 29087844)
32. Poldrugo F and Addolorato G (1999) The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies. Alcohol Alcohol 34:15-24.
33. Schlinger H and Poling A (1988) Evaluation of a procedure to measure the time course of a drug's behavioral action. J Pharmacol Methods 20:169-174.
34. Seabrook GR, Howson W, and Lacey MG (1990) Electrophysiological characterization of potent agonists and antagonists at pre- and postsynaptic GABAB receptors on neurones in rat brain slices. Br J Pharmacol 101:949-957.
35. Sevak RJ, France CP, and Koek W (2004) Neuroleptic-like effects of gamma-hydroxybutyrate: Interactions with haloperidol and dizocilpine. Eur J Pharmacol 483:289-293.
36. Sevak RJ, Koek W, and France CP (2005) Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy. Eur J Pharmacol 517:64-67. (Pubitemid 40910254)
37. Tallarida RJ (2000) Dose-response analysis, in Drug Synergism and Dose-Effect Data Analysis, pp 44-50, Chapman & Hall/CRC, Boca Raton, FL.
38. Weerts EM, Froestl W, Kaminski BJ, and Griffiths RR (2007) Attenuation of cocaineseeking by GABA B receptor agonists baclofen and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboons. Drug Alcohol Depend 89:206-213.
39. Winter JC (1981) The stimulus properties of gamma-hydroxybutyrate. Psychopharmacology (Berl) 73:372-375.
40. Wong CG, Gibson KM, and Snead OC 3rd (2004) From the street to the brain: Neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol Sci 25:29-34.
41. Yamada K, Yu B, and Gallagher JP (1999) Different subtypes of GABAB receptors are present at pre- and postsynaptic sites within the rat dorsolateral septal nucleus. J Neurophysiol 81:2875-2883. (Pubitemid 29283942)